Charles River Laboratories | 当期純利益



Net Income 変化する 日付
Agilent USD 318M 33M 2025-01
Align Technology USD 103.81M 12.16M 2024-12
Bio-Rad Laboratories USD -715800000 1.37B 2024-12
Bruker USD 13.7M 27.2M 2024-12
Cardinal Health USD 400M 16M 2024-12
Charles River Laboratories USD -215699000 284.38M 2024-12
Cigna USD 1.42B 685M 2024-12
CVS Health USD 1.64B 1.56B 2024-12
Danaher USD 1.09B 268M 2024-12
Dentsply International USD -430000000 64M 2024-12
Elevance Health USD 418M 598M 2024-12
Galapagos EUR 25.31M 75.74M 2024-12
Hologic USD 201M 22.4M 2024-12
Humana USD -693000000 1.17B 2024-12
Illumina USD 187M 518M 2024-12
Incyte USD 201.21M 94.76M 2024-12
IQVIA Holdings USD 437M 152M 2024-12
Laboratory Of America USD 143.4M 25.9M 2024-12
Lonza CHF 329M 85M 2024-06
McKesson USD 879M 638M 2024-12
Merck EUR 809M 202M 2024-09
Mettler Toledo International USD 252.3M 40.78M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 410M 4.06B 2024-12
Quest Diagnostics USD 222M 4M 2024-12
Revvity USD 94.64M 278K 2024-12
Thermo Fisher Scientific USD 1.83B 201M 2024-12
United Therapeutics USD 301.3M 7.8M 2024-12
UnitedHealth USD 5.54B 512M 2024-12
Walgreens Boots Alliance USD -265000000 2.74B 2024-11
Waters USD 231.4M 69.9M 2024-12
West Pharmaceutical Services USD 130.1M 5.9M 2024-12



Charles River Laboratories 当期純利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2025.